Company press releases

Displaying 101 - 143 of 143 results
Released Company Title Industry Topic
15 Nov 2023
08:30 CET 		THOR MEDICAL ASA Thor Medical ASA signs LOI for offtake with US and Scandinavian based clinical trial stage companies 20103010 Biotechnology Non-regulatory press releases
31 Oct 2023
16:45 CET 		THOR MEDICAL ASA Thor Medical ASA expands expertise and positions for growth with two experienced chemistry professionals 20103010 Biotechnology Non-regulatory press releases
31 Aug 2023
07:00 CEST 		THOR MEDICAL ASA Thor Medical ASA first half 2023 results 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
17 Aug 2023
15:39 CEST 		THOR MEDICAL ASA Invitation to presentation of Thor Medical ASA's first half results 2023 20103010 Biotechnology Non-regulatory press releases
05 Jul 2023
10:45 CEST 		NORDIC NANOVECTOR Thor Medical – New share capital and name registered 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
04 Jul 2023
07:54 CEST 		NORDIC NANOVECTOR Nordic Nanovector ASA – Disclosure of large shareholding 20103010 Biotechnology Major shareholding notifications
03 Jul 2023
21:34 CEST 		NORDIC NANOVECTOR Nordic Nanovector ASA: Notification of transactions by close associates of primary insiders 20103010 Biotechnology Mandatory notification of trade primary insiders
03 Jul 2023
18:08 CEST 		NORDIC NANOVECTOR The acquisition of Thor Medical AS is completed 20103010 Biotechnology Inside information
03 Jul 2023
16:11 CEST 		NORDIC NANOVECTOR Nordic Nanovector – Issuance of shares to former board members and restricted stock units (RSU) to current board members 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
29 Jun 2023
11:47 CEST 		NORDIC NANOVECTOR Nordic Nanovector ASA – Disclosure of large shareholding 20103010 Biotechnology Major shareholding notifications
29 Jun 2023
11:46 CEST 		NORDIC NANOVECTOR Nordic Nanovector ASA – Disclosure of large shareholding 20103010 Biotechnology Major shareholding notifications
29 Jun 2023
11:45 CEST 		NORDIC NANOVECTOR Nordic Nanovector ASA – Disclosure of large shareholding 20103010 Biotechnology Major shareholding notifications
28 Jun 2023
16:45 CEST 		NORDIC NANOVECTOR Nordic Nanovector - Appointment of Alf Bjørseth as CEO 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
28 Jun 2023
16:30 CEST 		NORDIC NANOVECTOR Nordic Nanovector - Completion of annual general meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
27 Jun 2023
14:26 CEST 		NORDIC NANOVECTOR NANOV AGM - Disclosure of proxies 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
27 Jun 2023
14:10 CEST 		NORDIC NANOVECTOR NANOV AGM - Publication of Exempted Document 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
23 Jun 2023
16:27 CEST 		NORDIC NANOVECTOR NANOV - Endring i forslag til vedtak 14 på GF 28.juni 2023 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
22 Jun 2023
14:36 CEST 		NORDIC NANOVECTOR Jostein Dahle, Chief Scientific Officer and Co-Founder, leaves the Company 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
22 Jun 2023
14:36 CEST 		NORDIC NANOVECTOR Jostein Dahle forlater Nordic Nanovector 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
15 Jun 2023
13:13 CEST 		NORDIC NANOVECTOR Nordic Nanovector - GF vedlegg 20103010 Biotechnology Årsrapporter og revisjonsberetninger
15 Jun 2023
13:13 CEST 		NORDIC NANOVECTOR Nordic Nanovector - AGM attachments 20103010 Biotechnology Annual financial and audit Reports
07 Jun 2023
14:46 CEST 		NORDIC NANOVECTOR Nordic Nanovector - Mandatory notification of trade - primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
07 Jun 2023
14:30 CEST 		NORDIC NANOVECTOR Nordic Nanovector - Notice of Annual General Meeting on 28 June 2023 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
07 Jun 2023
13:44 CEST 		NORDIC NANOVECTOR Styreleder kjøper aksjer i Nordic Nanovector 20103010 Biotechnology Meldepliktig handel for primærinnsidere
07 Jun 2023
13:44 CEST 		NORDIC NANOVECTOR The Chairman of the Board buys shares in Nordic Nanovector 20103010 Biotechnology Mandatory notification of trade primary insiders
06 Jun 2023
20:37 CEST 		NORDIC NANOVECTOR NANOV announces agreement to acquire Thor Medical 20103010 Biotechnology Innsideinformasjon
06 Jun 2023
20:10 CEST 		NORDIC NANOVECTOR Nordic Nanovector announces agreement to acquire Thor Medical, an emerging producer of alpha-emitters for radiopharmaceuticals to treat cancer 20103010 Biotechnology Inside information
18 Apr 2023
11:15 CEST 		NORDIC NANOVECTOR Nordic Nanovector Publishes Data from the PARADIGME Phase 2 Clinical Trials with Betalutin® on European Clinical Trials Database 20103010 Biotechnology Non-regulatory press releases
31 Mar 2023
08:45 CEST 		NORDIC NANOVECTOR NORDIC NANOVECTOR - ANNUAL GENERAL MEETING POSTPONED 20103010 Biotechnology Non-regulatory press releases
23 Mar 2023
11:00 CET 		NORDIC NANOVECTOR NORDIC NANOVECTOR - ANNUAL AND REMUNERATION REPORTS APPROVED 20103010 Biotechnology Annual financial and audit Reports
28 Feb 2023
07:00 CET 		NORDIC NANOVECTOR Nordic Nanovector ASA Results for the Second Half and Full Year 2022 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
21 Feb 2023
11:00 CET 		NORDIC NANOVECTOR Nordic Nanovector ASA: Invitation to Second Half and Full Year 2022 Results Presentation and Webcast 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
31 Jan 2023
23:15 CET 		NORDIC NANOVECTOR Nordic Nanovector ASA announces that Ludvik Sandnes has been appointed interim Chief Executive Officer (CEO) and Chief Financial Officer (CFO) 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
19 Jan 2023
20:10 CET 		NORDIC NANOVECTOR Nordic Nanovector board member resigns 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
16 Jan 2023
22:54 CET 		NORDIC NANOVECTOR Nordic Nanovector ASA Notes Publication of Letter by Largest Shareholder North Energy 20103010 Biotechnology Non-regulatory press releases
03 Jan 2023
17:59 CET 		NORDIC NANOVECTOR Nordic Nanovector ASA: Extraordinary General Meeting held 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
03 Jan 2023
10:57 CET 		NORDIC NANOVECTOR Flagging Nordic Nanovector ASA 20103010 Biotechnology Flagging
02 Jan 2023
17:44 CET 		NORDIC NANOVECTOR NOTIFICATION OF MAJOR HOLDINGS 20103010 Biotechnology Major shareholding notifications
16 Dec 2022
10:37 CET 		NORDIC NANOVECTOR Flaggemelding 20103010 Biotechnology Major shareholding notifications
16 Dec 2022
10:20 CET 		NORDIC NANOVECTOR Flagging i Nordic Nanovector ASA 20103010 Biotechnology Flagging
13 Dec 2022
11:48 CET 		NORDIC NANOVECTOR Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
13 Dec 2022
10:47 CET 		NORDIC NANOVECTOR Nordic Nanovector ASA - Notice of Extraordinary General Meeting on 3 January 2023 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
09 Dec 2022
18:32 CET 		NORDIC NANOVECTOR Nordic Nanovector update following shareholder vote against proposed merger with APIM Therapeutics 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State